Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 13, 2022May 17, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.45$1M-5.75%
May 10, 2022May 13, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.39$2M-6.57%
May 05, 2022May 09, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.37$898,921-3.42%
May 02, 2022May 04, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.38$3M-9.65%
Apr 27, 2022Apr 29, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.38$2M-6.34%
Apr 22, 2022Apr 26, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.39$1M-4.15%
Apr 19, 2022Apr 22, 2022Venbio Global Strategic Fund II L.P.
10%
SellCheckmate Pharmaceuticals, Inc.CMPI$10.41$6M-14.91%
Apr 27, 2021Apr 29, 2021Venbio Global Strategic Fund II L.P.
10%
BuyImpel Neuropharma IncIMPL$15$7M+14.02%
Aug 11, 2020Aug 13, 2020Venbio Global Strategic Fund II L.P.
10%
BuyCheckmate Pharmaceuticals, Inc.CMPI$15$3M+5.16%
Jul 01, 2020Jul 06, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$34.4$4M-3.70%
Mar 04, 2020Mar 06, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$23.76$1M-1.44%
Feb 28, 2020Mar 03, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$22.63$493,310-0.68%
Feb 25, 2020Feb 28, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$22.8$134,635-0.18%
Feb 10, 2020Feb 12, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$27.07$271,399-0.31%
Feb 06, 2020Feb 10, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$27.03$164,955-0.19%
Feb 04, 2020Feb 06, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$25.77$2M-2.48%
Jan 13, 2020Jan 14, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$20.23$10M-12.95%
Jan 08, 2020Jan 10, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$19.86$311,355-0.41%
Jan 06, 2020Jan 08, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$19.86$1M-1.88%
Jan 02, 2020Jan 06, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$19.71$699,721-0.90%
Dec 31, 2019Jan 03, 2020Venbio Global Strategic Fund II L.P.
10%
SellAkero Therapeutics, Inc.AKRO$23.96$343,259-0.36%
Jun 24, 2019Jun 25, 2019Venbio Global Strategic Fund II L.P.
10%
BuyAkero Therapeutics, Inc.AKRO$16$4M+5.95%
Jan 25, 2018Jan 29, 2018Venbio Global Strategic Fund II L.P.
10%
BuyMenlo Therapeutics, Inc.MNLO$17$5M+15.35%
Nov 13, 2017Nov 13, 2017Venbio Global Strategic Fund II L.P.
10%
BuyApellis Pharmaceuticals, Inc.APLS$14$2M+3.44%